Condition
Subclinical Hypercortisolism
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Unknown2
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT04833192Unknown
Evaluation of New Diagnostic Indicator of Subclinical Hypercortisolism
NCT04860180Not ApplicableUnknown
Effect of Surgical or Conservative Approach in Patients With Adrenal Incidentalomas
NCT02001051Phase 2TerminatedPrimary
Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Showing all 3 trials